FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 P/E (TTM) :99.8
ISIN Demat:INE203A01020 Div & Yield %:0.39 EPS (TTM) :83.21
Book Value (RS) :319.6 Market Cap (Rs Cr.):20761.13 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 611.57 440.29 38.90
Other Income 6.61 7.98 -17.17
PBIDT 51.44 51.42 0.04
Interest 1.06 0.33 221.21
PBDT 50.38 51.09 -1.39
Depreciation 3.84 9.07 -57.66
PBT 46.54 42.02 10.76
Tax 4.00 12.17 -67.13
Deferred Tax 9.95 -1.00 0.00
PAT 32.59 30.85 5.64

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)